Systematic review of topical amitriptyline for the treatment of neuropathic pain

Journal of Clinical Pharmacy and Therapeutics

Volumn 40, Issue 5, 2015, Pages 496-503

  Thompson, D F ^a   Brooks, K G ^a  

^a SOUTHWESTERN OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

amitriptyline; diabetes; neuropathic pain; topical therapy

Indexed keywords

AMITRIPTYLINE;

ANALGESIA; COMPARATIVE EFFECTIVENESS; DRUG EFFICACY; DRUG SAFETY; DRUG USE; EVIDENCE BASED MEDICINE; HUMAN; MEDICAL LITERATURE; META ANALYSIS; NEUROPATHIC PAIN; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PAIN INTENSITY; PHASE 3 CLINICAL TRIAL (TOPIC); PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RASH; REVIEW; RISK BENEFIT ANALYSIS; SKIN BURNING SENSATION; SKIN IRRITATION; STUDY DESIGN; SYSTEMATIC REVIEW;

EID: 84941025606     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/jcpt.12297     Document Type: Review

References (29)

1. Levine JP, Briley M,. The epidemiology of pain in depression. Hum Psychopharmacol, 2004; 19 (Suppl 1): S3-S7.
2. Yawn BP, Wollan PC, Weingarten TN, Watson JC, Hooten WM, Melton LJ,. The prevalence of neuropathic pain: clinical evaluation compared with screening tools in a community population. Pain Med, 2009; 10: 586-593.
3. Treede RD, Jensen TS, Campbell JN, et al,. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology, 2008; 70: 1630-1635.
4. Griebeler ML, Morey-Vargas OL, Brito JP, et al,. Pharmacologic interventions for painful diabetic neuropathy. An umbrella systematic review and comparative effectiveness network meta-analysis. Ann Intern Med, 2014; 161: 639-649.
5. National Institute for Health and Care Excellence (NICE). Neuropathic pain-pharmacological management. The pharmacological management of neuropathic pain in adults in non-specialist settings. London, UK: National Institute for Health and Care Excellence (NICE), 41, 2013 (Clinical guideline; no. 173).
6. Max MB,. Thirteen consecutive well-designed randomized trials show that antidepressants reduce pain in diabetic neuropathy and postherpetic neuralgia. Pain Forum, 1995; 4: 248-253.
7. Vranken JH,. Mechanism and treatment of neuropathic pain. Cent Nerv Syst Agents Med Chem, 2009; 9: 71-78.
8. Kaur S, Pandhi P, Dutta P,. Painful diabetic neuropathy: an update. Ann Neurosci, 2011; 18: 168-175.
9. Pachman DR, Barton DL, Watson JC, Loprinzi CL,. Chemotherapy-induced peripheral neuropathy: prevention and treatment. Clin Pharmacol Ther, 2011; 90: 377-387.
10. Gerner P, Kao G, Srinivasa V, Narang S, Wang GK,. Topical amitriptyline in healthy volunteers. Reg Anesth Pain Med, 2003; 28: 289-293.
11. Zur E,. Topical treatment of neuropathic pain using compounded medications. Clin J Pain, 2014; 30: 73-91.
12. Moher D, Liberati A, Tetzlaff J, Altman DG, the PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med, 2009; 151: 264-269.
13. Gibbons RJ, Smith S, Antman E, American College of Cardiology, American Heart Association. American College of Cardiology/American Heart Association clinical practice guidelines, part I. Circulation, 2003; 107: 2979-2986.
14. Lynch ME, Clark AJ, Sawynok J,. A pilot study examining topical amitriptyline, ketamine, and a combination of both in the treatment of neuropathic pain. Clin J Pain, 2003; 19: 323-328.
15. Lynch ME, Clark AJ, Sawynok J, Sullivan MJL,. Topical 2% Amitriptyline and 1% Ketamine in Neuropathic Pain Syndromes. Anesthesiology, 2005; 103: 140-146.
16. Ho K, Huh BK, White WD, Yeh C, Miller E,. Topical amitriptyline versus lidocaine in the treatment of neuropathic pain. Clin J Pain, 2008; 24: 51-55.
17. Barton DL, Wos EJ, Qin R, et al,. A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA. Support Care Cancer, 2011; 19: 833-841.
18. Gewandter JS, Mohile SG, Heckler CE, et al,. A phase III randomized, placebo-controlled study of topical amitriptyline and ketamine for chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study of 462 cancer survivors. Support Care Cancer, 2014; 22: 1807-1814.
19. Lynch ME, Clark AJ, Sawynok J, Sullivan MJ,. Topical amitripyline and ketamine in neuropathic pain syndromes: an open-label study. J Pain, 2005; 6: 644-649.
20. Uzaraga I, Gerbis B, Holwerda E, Gillis D, Wai E,. Topical amitriptyline, ketamine, and lidocaine in neuropathic pain caused by radiation skin reaction: a pilot study. Support Care Cancer, 2012; 20: 1515-1524.
21. Kopsky DJ, Hesselink JM,. High doses of topical amitriptyline in neuropathic pain: two cases and literature review. Pain Pract, 2011; 12: 148-153.
22. Liebregts R, Kopsky JM, Hesselink JM,. Topical amitriptyline in post-traumatic neuropathic pain. J Pain Symptom Manage, 2011; 41: e6-e7.
23. Kopsky DJ, Hesselink JM,. Multimodal stepped care approach involving topical analgesics for severe intractable neuropathic pain in CRPS type 1: a case report. Case Rep Med, 2011; 2011: 1-4.
24. Kopsky DJ, Liebregts R, Hesselink JM,. Central neuropathic pain in a patient with multiple sclerosis treated successfully with topical amitriptyline. Case Rep Med, 2012; 2012: 1-3.
25. Wiffen PJ, Derry S, Moore RA, et al,. Antiepileptic drugs for neuropathic pain and fibromyalgia-an overview of Cochrane reviews. December 20, 2013; from: Cochrane Database Syst Rev, Ipswich, MA. Available at: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD010567.pub2/pdf Accessed October 28, 2014.
26. Moore RA, Wiffen PJ, Derry S, Toelle T, Rice AS,. Gabapentin for chronic neuropathic pain and fibromyalgia in adults. May 20, 2014. from: Cochrane Database Syst Rev, Ipswich, MA. Available at: https://web-a-ebscohost-com.libnet.swosu.edu/ehost/results?sid=ed6f176d-ca6c-490d-8a2c-f970940af18d%40sessionmgr4002&vid=2&hid=4209&bquery=neuropathic+pain+gabapentin&bdata=JmRiPWNoaCZ0eXBlPTAmc2l0ZT1laG9zdC1saXZlJnNjb3BlPXNpdGU%3d Accessed October 28, 2014.
27. Saarto T, Wiffen PJ,. Antidepressants for neuropathic pain. Cochrane Database Syst Rev [serial online]. January 27, 2014; (1) Available from: Cochrane Database of systematic reviews, Ipswich, MA, Available at: https://web-a-ebscohost-com.libnet.swosu.edu/ehost/pdfviewer/pdfviewer?sid=ed6f176d-ca6c-490d-8a2c-f970940af18d%40sessionmgr4002&vid=5&hid=4209 Accessed October 28, 2014.
28. Moore RA, Derry S, Aldington D, Cole P, Wiffen PJ,. Amitriptyline for neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev [serial online]. October 25, 2012;(12) Available from: Cochrane Database of systematic reviews, Ipswich, MA. Available at: https://web-a-ebscohost-com.libnet.swosu.edu/ehost/detail/detail?vid=7&sid=ed6f176d-ca6c-490d-8a2c-f970940af18d%40sessionmgr4002&hid=4209&bdata=JnNpdGU9ZWhvc3QtbGl2ZSZzY29wZT1zaXRl#db=chh&AN=CD008242 Accessed October 28, 2014.
29. Hershman DL, Lacchetti C, Dworkin RH, et al,. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol, 2014; 32: 1941-1967.